the impact and long-term potential of olaratumab in soft tissue sarcoma
Published 7 years ago • 541 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
7:29
early data with olaratumab in soft tissue sarcoma
-
5:23
olaratumab efficacy in soft-tissue sarcoma
-
4:12
soft tissue sarcoma: role of olaratumab
-
0:50
dr. philip on olaratumab for soft tissue sarcoma
-
1:17
dr. tap on olaratumab in patients with soft tissue sarcoma
-
6:20
olaratumab doxorubicin for metastatic soft-tissue sarcoma
-
5:23
practical implications of using olaratumab in patients with sts
-
1:17
dr. may on olaratumab activity in pediatric bone and soft tissue sarcoma
-
3:28
toxicity of olaratumab and doxorubicin
-
1:56
the role of olaratumab in sarcoma
-
3:59
os vs pfs with olaratumab
-
1:13
dr. robin jones on olaratumab and doxorubicin in patients with soft tissue sarcoma
-
12:21
appropriate patients for olaratumab doxorubicin
-
2:19
olaratumab plus doxorubicin in advanced soft tissue sarcoma
-
5:34
soft tissue sarcoma: factors impacting initial approach
-
5:40
changing treatment landscape in soft tissue sarcoma
-
1:03
dr. van tine discusses the development of olaratumab in sarcoma
-
1:06
dr. trent on research efforts in bone and soft tissue sarcomas
-
3:40
management of oligometastases in soft-tissue sarcoma